DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
E0302 (mecobalamin) ( DrugBank:
Mecobalamin
)
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
2
筋萎縮性側索硬化症
2
2. 筋萎縮性側索硬化症
臨床試験数
:
645
/
薬物数
:
589
- (
DrugBank
:
163
) /
標的遺伝子数
:
150
-
標的パスウェイ数
:
225
10
50
100
ALL
diseases per page:
Showing 1 to 2 of 2 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT00445172
(
ClinicalTrials.gov
)
February 2008
6/3/2007
A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis (ALS)
Drug:
E0302 (mecobalamin)
Eisai Co., Ltd.
NULL
Completed
20 Years
N/A
All
135
Phase 2/Phase 3
Japan
2
NCT00444613
(
ClinicalTrials.gov
)
April 2007
6/3/2007
A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II/III Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis (ALS)
Drug:
E0302 (mecobalamin)
;Drug: Placebo
Eisai Co., Ltd.
NULL
Completed
20 Years
N/A
Both
373
Phase 2/Phase 3
Japan